Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

2.1K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.1K
Adrenergic Agonists: Indirect-Acting Agents01:25

Adrenergic Agonists: Indirect-Acting Agents

2.5K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
2.5K
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

3.0K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
3.0K
Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants

2.0K

Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A red-emitting, genetically encoded indicator for two-photon voltage recording in vivo.

bioRxiv : the preprint server for biology·2026
Same author

Improving sleep on the inpatient general, non-stroke neurology service: A quasi-experimental interventional trial.

Journal of hospital medicine·2026
Same author

Amphetamine in adolescence induces a sex-specific mesolimbic dopamine phenotype in the adult prefrontal cortex.

Communications biology·2025
Same author

Longitudinal changes on cranial magnetic resonance imaging in relapsing giant cell arteritis.

Seminars in arthritis and rheumatism·2025
Same author

Complementary cortical and thalamic contributions to cell-type-specific striatal activity dynamics during movement.

bioRxiv : the preprint server for biology·2025
Same author

Ultraslow serotonin oscillations in the hippocampus delineate substates across NREM and waking.

eLife·2025

Related Experiment Video

Updated: Jan 11, 2026

Presynaptic Dopamine Dynamics in Striatal Brain Slices with Fast-scan Cyclic Voltammetry
08:49

Presynaptic Dopamine Dynamics in Striatal Brain Slices with Fast-scan Cyclic Voltammetry

Published on: January 12, 2012

22.4K

Subsecond dopamine fluctuations do not specify the vigor of ongoing actions.

Haixin Liu1, Riccardo Melani1, Marta Maltese1

  • 1Neuroscience Institute, New York University Grossman School of Medicine and Fresco Institute for Parkinson's and Movement Disorders, New York University Langone Health, New York, NY, USA.

Nature Neuroscience
|November 10, 2025
PubMed
Summary

Dopamine (DA) is not required for vigorous movements in mice. Subsecond DA transients in the striatum do not control movement vigor, challenging existing theories of motor control.

More Related Videos

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0
07:41

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0

Published on: June 5, 2017

10.3K
Creating Dynamic Images of Short-lived Dopamine Fluctuations with lp-ntPET: Dopamine Movies of Cigarette Smoking
14:21

Creating Dynamic Images of Short-lived Dopamine Fluctuations with lp-ntPET: Dopamine Movies of Cigarette Smoking

Published on: August 6, 2013

18.8K

Related Experiment Videos

Last Updated: Jan 11, 2026

Presynaptic Dopamine Dynamics in Striatal Brain Slices with Fast-scan Cyclic Voltammetry
08:49

Presynaptic Dopamine Dynamics in Striatal Brain Slices with Fast-scan Cyclic Voltammetry

Published on: January 12, 2012

22.4K
Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0
07:41

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0

Published on: June 5, 2017

10.3K
Creating Dynamic Images of Short-lived Dopamine Fluctuations with lp-ntPET: Dopamine Movies of Cigarette Smoking
14:21

Creating Dynamic Images of Short-lived Dopamine Fluctuations with lp-ntPET: Dopamine Movies of Cigarette Smoking

Published on: August 6, 2013

18.8K

Area of Science:

  • Neuroscience
  • Motor Control
  • Neuropharmacology

Background:

  • Dopamine (DA) plays a crucial role in motor control and action vigor.
  • The precise mechanisms by which DA influences motor command gain are not fully understood.
  • Existing models suggest DA is essential for specifying movement vigor.

Purpose of the Study:

  • To investigate the necessity and sufficiency of subsecond dopamine transients in the striatum for specifying movement vigor.
  • To elucidate the role of dopamine in motor command gain under physiological conditions.
  • To re-evaluate dopamine's contribution to motor control in health and Parkinson's disease.

Main Methods:

  • Utilized in vivo electrophysiology and behavioral analysis in mice.
  • Manipulated dopamine levels in the striatum with subsecond temporal resolution.
  • Assessed the impact of dopamine transients on forelimb movement vigor during ongoing tasks.

Main Results:

  • Subsecond dopamine transients in the striatum were found to be neither required nor sufficient for determining the vigor of ongoing forelimb movements.
  • Movement vigor could be specified independently of rapid dopamine fluctuations in the striatum.
  • These findings contradict the hypothesis that rapid dopamine signaling directly gates motor command gain.

Conclusions:

  • Subsecond dopamine transients in the striatum do not directly regulate the gain of motor commands for movement vigor.
  • The role of dopamine in motor control may be more complex than previously assumed, potentially involving slower modulatory effects.
  • This research necessitates a revision of current understanding of dopamine's function in motor control, particularly relevant for Parkinson's disease.